BullFrog AI granted Nasdaq second compliance period for bid price
Tickers BFRG
Nasdaq gave BullFrog AI until February 8, 2027 to regain the $1.00 minimum bid price. Stockholders approved a reverse stock split at a ratio of not less than 1-to-2 and not more than 1-to-15.
Key facts
- Company
- BullFrog AI Holdings, Inc. (NASDAQ: BFRG)
- News type
- Listings
- Primary source
- BullFrog AI Holdings, Inc. 8-K (2026-08-20)

BullFrog AI Holdings, Inc. (NASDAQ: BFRG) said in a Form 8-K dated August 18, 2026, that Nasdaq has granted it a second compliance period to regain compliance with the minimum bid price requirement. The company has not yet regained compliance, but Nasdaq determined it is eligible for an additional 180 calendar days, until February 8, 2027. The filing was signed by Vininder Singh, Chief Executive Officer, on August 20, 2026.
How the deficiency began
On February 10, 2026, Nasdaq's listing staff notified BullFrog AI that, for the 30 consecutive business days before that letter, the closing bid price of its common stock, par value $0.00001 per share, was below $1.00 per share. That is the minimum closing bid price required for continued listing under Nasdaq Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(A), the company received an initial compliance period of 180 calendar days, or until August 10, 2026, to regain compliance.
The second compliance period
On August 18, 2026, Nasdaq told the company that it had not yet regained compliance but was eligible for the second compliance period, ending February 8, 2027. BullFrog AI told Nasdaq that, if the deficiency is not cured organically, it intends to cure it by effecting a reverse stock split before the end of that period.
At a Special Meeting of Stockholders in October 2025, the company received stockholder approval to effect a reverse stock split at a ratio of not less than 1-to-2 and not more than 1-to-15. The ratio and timing are at the discretion of the board of directors.
Under the terms described in the filing, if the closing bid price is at least $1.00 per share for a minimum of 10 consecutive business days during the second period, Nasdaq will provide written confirmation of compliance. Nasdaq's staff may require a bid price of at least $1.00 for longer than 10 consecutive business days, but generally no more than 20 consecutive business days, before it determines that the company has shown an ability to maintain long-term compliance.
What happens if the deadline passes
If BullFrog AI does not regain compliance by February 8, 2027, its listed securities will be subject to delisting. The company would then have the right to appeal a delisting determination to a Nasdaq Hearings Panel.
The company said it intends to monitor the closing bid price of its common stock and assess potential options to regain compliance with the minimum bid price requirement. The filing states that there can be no assurance the company will regain compliance during the second compliance period or maintain compliance with the other Nasdaq listing requirements.
Financial position
BullFrog AI reported revenue of $116,670 for the fiscal year ended December 31, 2025. Research and development expense was $1.8 million in 2025, compared with $2.2 million in 2024. The company reported a net loss of $6.5 million for 2025 and a net loss of $7.0 million for 2024.
Operating activities used $5.5 million of cash in 2025 and $5.6 million in 2024. At the end of 2024, cash and cash equivalents were $5.4 million. The company reported cash and cash equivalents of $6.9 million as of June 30, 2026, in its quarterly report on Form 10-Q.
The filing lists the company's common stock under the symbol BFRG and its tradeable warrants under BFRGW, both on The Nasdaq Capital Market.
The risks ahead
BullFrog AI has until February 8, 2027 to bring its closing bid price to at least $1.00 for the required run of days, or its listed securities face delisting with a right to appeal to a Nasdaq Hearings Panel. The company says it intends to use a reverse stock split if the price does not recover on its own, and the ratio and timing are left to the board. The filing says there is no assurance it will regain or keep compliance. Behind the listing issue, the company lost $6.5 million in 2025 and its operations used $5.5 million of cash, against revenue of $116,670.
aibio